ÎÚÑ»´«Ã½

Creative outreach and testing strategies empower people most at risk of infection.

Widespread polio vaccination nearly eliminated the virus from most countries. Why are we seeing outbreaks now?

With monkeypox case counts rising, metrics could tell us if the epidemiological picture is pointing in the right direction.

Tuberculosis was the world’s biggest infectious disease killer—until COVID-19 came along.

A new report confirming a Wuhan seafood market as SARS-CoV-2’s origin shines a light on the need for critical research to prevent future pandemics.

Following the declaration of monkeypox a public health emergency, Johns Hopkins experts gathered to discuss vaccines, prevention, testing, treatment, and ways of reducing stigma around the outbreaks.

The course is intended for professionals and practitioners who make decisions about public health policies, and aims to make them informed consumers of infectious disease models.

How yet another virus has escalated to crisis levels in a short period of time, the danger of ignoring health challenges facing the developing world, and the future of global public health challenges.

Special issue includes research and commentary addressing important considerations for national PrEP program that would lower prices and expand access.

Omicron is mutating in giant leaps, challenging vaccine efficacy and complicating treatment. But this fall, broad spectrum bivalent vaccines may help mitigate the seemingly never ending spread of COVID-19.

The devastating parasitic disease is expanding its footprint beyond endemic areas of South America, but surveillance is still lacking.

As fungi adapt to warmer temperatures and develop resistance to drugs, we need to bolster our defenses.